Lingzhi Yan

Yuncheng University — China

Medicine · Health Sciences

22h-index1.5kcitations140works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(52), CAR-T cell therapy research(17), Protein Degradation and Inhibitors(15), Acute Myeloid Leukemia Research(14), Chronic Lymphocytic Leukemia Research(14)

Publications136 total

Development of colloidal gold-labeled dual-probe lateral flow immunoassay for sensitive aflatoxin B1 detection by a signal amplification strategy
Analytical Methods·2025
CLINICAL STUDY ON THE PSYCHOLOGICAL HEALTH STATUS AND INFLUENCING FACTORS OF PATIENTS WITH CHRONIC RENAL FAILURE UNDERGOING HEMODIALYSIS
Schizophrenia Bulletin·2025
Efficacy and safety of aponermin-carfilzomib-dexamethasone-based regimens for relapsed/refractory multiple myeloma: A Phase 2 prospective multi-center study
Blood·2025
Treatment of high-risk newly diagnosed multiple myeloma with minimal residual disease-guided therapy：daratumumab, carfilzomib, lenalidomide, and dexamethasone (DKRd)
Blood·2025Open Access
Sustained MRD negativity via multimodal NGS/NGF overcomes high-risk cytogenetics and predicts long-term survival in transplant-eligible multiple myeloma: A real-world cohort study
Blood·2025Open Access
Long-term follow-up of zevor-cel in patients with relapsed/refractory multiple myeloma
Blood Advances·2025Open Access
[Renal response and prognosis of newly diagnosed patients with multiple myeloma with renal impairment applying VRD and autologous hematopoietic stem cell transplantation].
PubMed·2025Open Access
Long Term Follow-Up of Zevor-Cel in Patients with Relapsed/Refractory Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2025
Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main clone
British Journal of Haematology·2025· 1 citedOpen Access
Redefining multiple myeloma treatment: Advances, challenges, and future directions in immunotherapy
Chinese Medical Journal·2025· 2 citedOpen Access
A replenishing signal Hadamard transform ion mobility spectrometry with enhanced performance
Sensors and Actuators B Chemical·2025· 1 cited
Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma
Scientific Reports·2025· 1 citedOpen Access
Adaptive genetic algorithm for computer course scheduling system under the background of educational informatization
Systems and Soft Computing·2025· 1 citedOpen Access
A Replenishing Signal Hadamard Transform Ion Mobility Spectrometry with a Tri-State Ion Shutter
2025
Advanced Deep Learning Methods for Protein Structure Prediction and Design
arXiv (Cornell University)·2025Open Access
Generative Adversarial Networks Bridging Art and Machine Intelligence
arXiv (Cornell University)·2025Open Access
A Rare Case of Triple‐Hit Ultra‐High‐Risk Multiple Myeloma Harboring t(4;14), t(14;20), and Gain(1q)
International Journal of Laboratory Hematology·2025
From In Silico to In Vitro: A Comprehensive Guide to Validating Bioinformatics Findings
ArXiv.org·2025· 2 citedOpen Access
From Aleatoric to Epistemic: Exploring Uncertainty Quantification Techniques in Artificial Intelligence
arXiv (Cornell University)·2025· 5 citedOpen Access
The Diagnostic and Differential Value of the Serum Albumin-to-Globulin Ratio in Multiple Myeloma
Clinical Laboratory·2025
page 1 of 7Next →

Frequent Co-authors

Chengcheng Fu(21), Depei Wu(17), Jingjing Shang(15), Xiaolan Shi(14), Song Jin(13), Weiqin Yao(12), Liqing Kang(10), Daohong Zhang(9), Jianlong Wang(8), Tong Bu(7), Lei Yu(7), Ying Yao(7), Qiong Huang(6), Guanghua Chen(6), Jin Zhou(6), Depei Wu(6), Yang Xu(6), Suning Chen(6), Shuang Yan(6), Ziqian Bi(6)